gp100 antigen A melanoma-associated antigen. When administered in a vaccine formulation, gp100 antigen may stimulate a cytotoxic T cell HLA-A2.1-restricted immune response against tumors that express this antigen, which may result in a reduction in tumor size. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
